The Scottish Cryo-EM consortium has chosen the JEOL JEM-Z300FSC CRYO ARM™ 300 as their preferred automated Cryo Transmission Electron Microscope (Cryo-TEM) for the Scottish Centre for Macromolecular Imaging (SCMI). Further information: JEOL UK press release Also See: CRYO ARM™ 200 Field Emission Cryo-electron MicroscopeCRYO ARM™ 300 Field Emission Cryo-electron Microscope # # # JEOL USA,... Read more
Hilden, Germany, and Tokyo, Japan, February 8th, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Japan’s Ministry of Health Labor and Welfare has approved QuantiFERON®-TB Gold Plus (QFT®-Plus) as an in vitro diagnostic to detect tuberculosis (TB) infection. QFT-Plus is the fourth generation of QIAGEN’s market-leading QuantiFERON-TB technology, combining innovative... Read more
Agilent to Support Korea Doping Control Center Facility to test urine samples from thousands of athletes SANTA CLARA, Calif., Feb. 8, 2018 Agilent Technologies Inc. (NYSE: A) today announced it will collaborate with the Doping Control Center in Seoul, South Korea, to ensure that athletes from around the world are quickly and accurately tested to... Read more
The GE Athlete Management Solution (AMS) collects multiple kinds of data, including imaging scans, patient vitals, and venue, event and sport-specific information, and provides real-time dashboards that can help inform medical staff and allow them to personalize treatment for athletes while identifying trends in injury and illness across the Games. For example, the tool can... Read more
Az alkalmazás olyan értékes információkat tesz elérhetővé egy helyen és felületen, mint például a sportoló sérüléseinek és betegségének adatai, a helyszín adatai, az alkalmazott sport- és edzési- eljárások. A felhőben tárolt információk alapján a Játékok egészségügyi személyzete átfogó képet kaphat a sportolók egészségi állapotáról, és gyors döntéseket hozhat a szükséges beavatkozás, vagy kezelés módjáról. Az... Read more
FRANKLIN LAKES, N.J., Feb. 2, 2018 /PRNewswire/ — As previously disclosed, on December 29, 2017, BD (Becton, Dickinson and Company) (NYSE: BDX) completed the acquisition of C. R. Bard, Inc. (“Bard”). In relation to the acquisition, BD has provided supplemental, unaudited historical financial information on the Investor page of its website at www.bd.com/investors. This information presents... Read more
One of the essential pathological signatures of Alzheimer’s disease is deposition in the brain of an abnormal protein, called Aβ-amyloid (Aβ). About three decades before the onset of dementia symptoms, the deposition starts silently, without any sign of cognitive abnormalities. It is estimated that about 20-40 % of the general elderly population have a significant... Read more
Basel, 26 January 2018 CHMP recommends EU approval of Roche’s Hemlibra for people with haemophilia A with inhibitors Hemlibra demonstrated superior efficacy compared to prior treatment with bypassing agents in two phase III studies across age groups With once-weekly subcutaneous (under the skin) administration, Hemlibra may help reduce the burden of managing haemophilia A Roche... Read more
Basel, 26 January 2018 CHMP recommends EU approval of Roche’s Hemlibra for people with haemophilia A with inhibitors Hemlibra demonstrated superior efficacy compared to prior treatment with bypassing agents in two phase III studies across age groups With once-weekly subcutaneous (under the skin) administration, Hemlibra may help reduce the burden of managing haemophilia A Roche... Read more